Welcome to our dedicated page for Phreesia news (Ticker: PHR), a resource for investors and traders seeking the latest updates and insights on Phreesia stock.
Phreesia, Inc. (NYSE: PHR) is a healthcare technology company focused on patient activation, digital intake, outreach and education for healthcare providers, life sciences companies and other organizations. The Phreesia news feed on Stock Titan highlights company announcements, financial updates and product developments that shape how it engages patients and supports healthcare workflows.
Investors and industry followers can use this page to review earnings releases and outlook updates, where Phreesia reports quarterly revenue, subscription and related services, payment processing fees, network solutions revenue and key metrics such as average healthcare services clients and revenue per client. These updates often include management commentary on operating leverage, cash flows and non-GAAP measures like Adjusted EBITDA.
The news stream also features transaction and financing disclosures, including details about the acquisition of AccessOne Parent Holdings, Inc., a provider of financing solutions for healthcare receivables, and related bridge loan and credit facility arrangements. These items are relevant for understanding Phreesia’s growth strategy and capital structure.
In addition, readers will find product and innovation news, such as the launch of Phreesia VoiceAI, an AI-driven phone solution for managing patient calls, and partnership and recognition stories, including the collaboration with Sesame Workshop and inclusion in rankings like the Deloitte Technology Fast 500™ and Capterra Shortlists. Bookmark this page to follow how Phreesia communicates its performance, platform enhancements and strategic initiatives over time.
Phreesia (NYSE: PHR) announced that Tiffany McGee, assistant general counsel, commercial contracts, was named to The Software Report’s 2025 Top Women Leaders in Software list on March 12, 2026. This marks the eighth consecutive year a Phreesia woman has been included.
McGee negotiates complex commercial agreements, led Phreesia’s shift to fully digital contracting to shorten deal cycles and improve close rates, brings over 18 years of legal experience, and mentors colleagues through the company’s mentorship program.
Phreesia (NYSE:PHR) was named to the 2026 Capterra Shortlist for Appointment Scheduling, an independent recognition based on user ratings and popularity signals. Phreesia previously made four Capterra Shortlists in 2025, and holds a 4.3/5 rating from 166 reviews on Capterra.
This acknowledgment highlights customer feedback on Phreesia's patient intake, outreach, and scheduling tools and underscores the product's visibility and user satisfaction in software search data.
Phreesia (NYSE: PHR) announced that Tara Sheehy, Senior Director of Client Experience for Phreesia Network Solutions, was named to the MM+M Women to Watch class of 2026. Sheehy oversees more than 20 major accounts and leads an 18-person team, credited with driving new business growth, account expansion and consistent client retention.
Colleagues highlighted her mentorship, leadership during rapid growth, and contributions to client experience and healthcare marketing.
Phreesia Network Solutions (NYSE: PHR) announced ProviderConnect on March 3, 2026, a new clinician-targeted offering that engages healthcare providers during the pre-appointment window.
ProviderConnect uses real-world care signals, advanced AI, and privacy-first design to deliver timely, patient-relevant resources to clinicians, building on the company's PatientConnect platform.
Phreesia (NYSE: PHR) appointed Jon Kessler to its Board, effective April 6, 2026, while directors Edward L. Cahill and Michael Weintraub will retire at the 2026 Annual Meeting. The Board will reduce to seven members and a new chair will be named after Weintraub's retirement.
Since the 2019 IPO, revenue grew from about $100 million to over $460 million for the twelve months ended October 31, 2025, and Phreesia enabled roughly 170 million patient visits in 2024.
Phreesia (NYSE: PHR) will report fiscal fourth quarter and fiscal year 2026 results after market close on Monday, March 30, 2026. The company will publish a press release and quarterly stakeholder letter on its investor site, then host a conference call and webcast at 5:00 PM ET the same day.
Live participation details, conference dial‑in numbers, conference code 7404611, and an on‑demand replay (available ~90 days) are provided on the Events & Presentations page of ir.phreesia.com.
Phreesia (NYSE: PHR) announced that CEO and co-founder Chaim Indig was named to The Software Report’s Top 50 CEOs of 2025, his third time receiving the honor.
Phreesia supports more than 4,400 healthcare organizations with its SaaS platform. The award recognizes demonstrated leadership, measurable contributions, and sustained organizational performance.
Phreesia (NYSE: PHR) was named one of The Software Report’s Top 50 Software Companies of 2025 on December 18, 2025. This is the fourth consecutive year Phreesia made the list and the first time it ranked in the Top 10. The award cites product excellence, organizational strength, culture, growth, and management caliber.
In 2025 Phreesia introduced Phreesia VoiceAI, a conversational automation tool for healthcare phone calls, which the company said supports its goal of making care easier for patients and providers.
Phreesia (NYSE: PHR) reported fiscal Q3 2026 results for the quarter ended October 31, 2025: total revenue $120.3M (+13% YoY), AHSCs 4,520 (+7% YoY), and revenue per AHSC $26,622 (+6% YoY). Net income was $4.3M versus a net loss of $14.4M year-ago; Adjusted EBITDA $29.1M versus $9.8M year-ago. Cash and cash equivalents were $106.4M as of October 31, 2025.
Post-quarter, Phreesia completed the AccessOne acquisition for approximately $160M on November 12, 2025, funded in part by a $110M 364-day bridge loan. Fiscal 2026 outlook was updated to $479M–$481M revenue and $99M–$101M Adjusted EBITDA. Fiscal 2027 outlook introduced: $545M–$559M revenue (14–16% growth) and $125M–$135M Adjusted EBITDA; AccessOne is expected to represent ~6.5% of fiscal 2027 revenue.
Phreesia (NYSE: PHR) announced that Megan Turco, Director of Client Experience for Phreesia Network Solutions, was named to MM+M’s 2025 40 Under 40. Since joining in 2018, Turco advanced through five roles and scaled the Client Experience team from four people to more than 50. She leads a sales organization servicing 80+ life sciences and agency clients and has overseen programs that reached millions of patients.
The team exceeded targets for four consecutive years with double‑digit annual revenue growth, and internal surveys show 95% client ratings of very good/excellent and 94% reporting great service.